Trump Halts Federal Funding For New York Fraud Unit
The Trump administration has suspended federal funding for New York’s Medicaid Fraud Control Unit (MFCU), accusing the state of failing to adequately investigate and prosecute Medicaid fraud despite receiving substantial federal support. The move marks the second time in less than a month that the administration has taken similar action against a state Medicaid fraud unit, following a funding suspension involving Hawaii.
The decision was announced by the U.S. Department of Health and Human Services (HHS) in a letter sent to New York Attorney General Letitia James, whose office oversees the Medicaid Fraud Control Unit. HHS informed the state that it would deny federal certification for the unit, effectively cutting off federal funding that supports investigations into Medicaid provider fraud and abuse, as well as cases involving patient neglect and financial exploitation in healthcare facilities.
Federal officials said the decision was based on the unit’s performance compared with similar programs in other large states. According to HHS, New York has consistently produced fewer criminal fraud prosecutions than expected despite having one of the nation’s largest Medicaid programs. While the department acknowledged that New York had improved its performance in 2026 and achieved success in several civil enforcement actions, officials concluded that those improvements were insufficient to justify continued federal certification.
The funding suspension could have broader consequences beyond the fraud unit itself. Federal law requires states to maintain certified Medicaid Fraud Control Units as a condition of participating in certain federal Medicaid funding programs. If New York cannot restore certification, questions could arise regarding its continued eligibility for portions of federal Medicaid funding that helps provide healthcare coverage for approximately 6.4 million low-income New Yorkers. State officials, however, emphasized that Medicaid benefits themselves are not immediately affected by the decision.
Attorney General Letitia James strongly criticized the administration’s action, calling it counterproductive to the government’s stated goal of fighting healthcare fraud. James argued that cutting funding for investigators responsible for uncovering fraud would ultimately benefit criminals rather than taxpayers. She also noted that New York’s Medicaid Fraud Control Unit has recovered more than $627 million through fraud investigations and enforcement actions between 2019 and 2025, including a recent criminal case involving approximately $9 million in alleged Medicaid fraud. James said her office is exploring legal options to challenge the funding suspension.
The action forms part of the Trump administration’s broader campaign to strengthen oversight of federal healthcare programs and combat fraud. Earlier this month, the administration suspended funding for Hawaii’s Medicaid Fraud Control Unit, citing similar concerns about low prosecution numbers. Hawaii has appealed that determination, arguing that the federal government relied on flawed performance metrics.
The administration has increasingly emphasized healthcare fraud enforcement as a national priority. Federal officials have recently announced large-scale Medicare and Medicaid fraud investigations resulting in criminal charges against hundreds of defendants nationwide. Administration officials argue that stronger oversight is necessary to protect taxpayer dollars and preserve the long-term financial stability of federal healthcare programs.
New York officials dispute the federal government’s assessment, arguing that the state’s fraud unit often handles more complex investigations that take longer to prosecute than those in other jurisdictions. They also contend that evaluating performance primarily by counting criminal cases fails to recognize substantial civil recoveries and sophisticated fraud investigations that return significant amounts of money to Medicaid programs. State officials maintain that their enforcement efforts have saved taxpayers hundreds of millions of dollars and protected vulnerable Medicaid beneficiaries from fraudulent healthcare providers.
The dispute could ultimately be resolved in federal court if New York challenges the certification decision. Such litigation would likely focus on whether HHS properly applied federal performance standards and whether the agency acted within its statutory authority when denying certification. Until then, the funding suspension adds to ongoing legal and political disputes between the Trump administration and several Democratic-led states over healthcare policy, Medicaid administration, and federal oversight.
⚖️ Key Legal Outcomes
- The Trump administration suspended federal funding for New York’s Medicaid Fraud Control Unit.
- HHS denied the unit’s federal certification, citing underperformance in criminal fraud prosecutions.
- Attorney General Letitia James vowed to challenge the decision and explore legal remedies.
- The suspension follows a similar funding cut imposed on Hawaii’s Medicaid fraud unit.
- The action could affect New York’s eligibility for certain federal Medicaid funding if certification is not restored.
📌 Why It Matters
- Tests federal authority to oversee state Medicaid fraud enforcement.
- Could impact healthcare fraud investigations in New York.
- Highlights ongoing disputes between the Trump administration and Democratic-led states.
- Raises questions about how Medicaid fraud units should be evaluated.
- May lead to another significant legal battle over federal healthcare funding.
RELATED:
Trump Administration Charges 455 In Massive Healthcare Fraud Crackdown
